Prominent nurse unions are critical of new CDC mask guidance; Sanofi, GlaxoSmithKline announce positive phase 2 results of their joint COVID-19 vaccine; Georgia officials report significant fentanyl overdose rates tied to tainted substances.
Amid a new guidance by the CDC stating that fully vaccinated individuals no longer need to wear masks or physically distance outside and inside, except for health care settings and crowded indoor facilities, the largest US nurses union, National Nurses United, and an affiliate, the California Nurses Association, were critical of the new guidelines, stating that it is not based on science and puts the health of nurses, front-line workers, and patients at risk. Reported by San Francisco Chronicle, the union noted that some information on the COVID-19 vaccine, such as length of protection and transmission when vaccinated, remains unclear.
Today, Sanofi and GlaxoSmithKline (GSK) announced positive results from a phase 2 clinical trial of their joint COVID-19 vaccine, with all ages studied found to develop strong levels of neutralizing antibodies similar to those found in people who have recovered from the virus. Reported by STAT, information regarding results of the trial are still limited with full data findings set to be published shortly in a peer-reviewed journal; higher favorable response from the vaccine was reported in people 18 to 59 years old. Both companies said that a large international phase 3 trial will begin in a few weeks.
Reported by the Associated Press, Georgia officials said that clusters of fentanyl overdoses linked with tainted pills falsely sold as Xanax or Percocet have been reported across Savannah and Columbus, following a set of cases initially found in Augusta. Notably, overdoses in Chatham County, whose largest city is Savannah, reported 336 suspected overdoses from January 1 to April 19, 2021, compared with 368 overdoses reported in all of 2020.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More